Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Wharf Rat who wrote (1285402)	12/30/2020 11:16:48 AM
From: Maple MAGA	Read Replies (1) \| Respond to of 1574683

Swiss Patient Dies Shortly After Receiving Pfizer COVID Vaccine BY TYLER DURDEN WEDNESDAY, DEC 30, 2020 - 8:55 After an Israeli man reportedly died just 2 hours after receiving his first dose of the COVID-19 vaccine, authorities in the Swiss Canton of Lucerne said on Wednesday that one of the first people in the country to receive the vaccine has died, though whether his death had anything to do with the inoculation hasn't yet been determined. The canton has yet to release any additional details about the exact amount of time that passed between the inoculation and the man's death. Lucerne was the site of the first vaccinations in Switzerland beginning last week, with a shot from Pfizer and its German partner BioNTech given primarily to elderly people. Switzerland has received 107K vaccine doses, so far, and expects to get 250K per month starting next year. 00:08 / 01:01 "We are aware of the case," a spokesperson said, before adding that the death had been referred to Swiss drugs regulator Swissmedic. Swissmedic didn't comment further. Pfizer and BioNTech’s vaccine is the only vaccine approved, so far, in Switzerland. The EU has just started approving the jabs on an emergency-use basis, with the first injections starting earlier this week.